Despite extensive research during the past few years, the mechanism of lysis by cytolytic T lymphocytes (CTL) 1 is poorly understood (1). Even less well elucidated is the nature of the antigen-specific T cell receptor (2, 3). Although both of these activities must be present for a CTL to specifically recognize and lyse a target cell, the cellular requirements for their expression remain obscure. Recently, preliminary studies from this laboratory (4) have shown that "cybrids" obtained by fusion of enucleated cloned CTL with noncytolytic EL4 cells could display specific cytolytic activity. Although this activity was low and somewhat variable, it seemed to indicate that participation of the CTL nucleus was not necessary.An alternative approach to investigate the putative role of membrane components in cytolytic activity would be to transfer CTL-derived material to noncytolytic recipient cells via synthetic liposomes. In this context, work from Jakobovits et al. (5) demonstrated that T or B lymphoid cells acquired the ability to respond to normally nonstimulatory mitogens upon fusion with liposomes containing B or T lymphocyte membrane components. In other words, B cells fused with T cell membrane components could now respond to concanavalin A (Con A); likewise, T cells fused with B cell membrane components could be stimulated by iipopolysaccharide (LPS). These results indicated that the inability of a particular lymphocyte population to respond to a specific mitogen was due to the lack of suitable membrane receptors, but not to an inherent cellular (nuclear) defect.In the present study, we investigated the requirements for the expression of antigen specificity and cytolytic activity by constructing liposomes composed of detergent-solubilized CTL clones (separated from nuclear constituents), exogenous lipids, and Sendal virus envelope proteins, and fusing these liposomes with various noncytolytic cell lines. The resultant fusion products were observed to Abbreviations used in this paper: Con A, concanavalin A; CTL, cytolytic T lymphocyte; DPPC, dipalmitoylphosphatidylcholine; DMEM, Dulbecco's modified Eagle's medium; E/T, effector/target ratio; F, Sendal virus fusion protein; FBS, fetal bovine serum; FITC, fluorescein isothiocyanate; HN, Sendal virus hemagglutin/neuraminidase protein; IL-2, interleukin 2; LPS, lipopolysaccharide; mAb, monoclonal antibody; MoLV, Moloney leukemia virus; NP-40, Nonidet P-40; PBS, phosphatebuffered saline.J. ExP. MED.